Увійти

Готові списки джерел за темами / Suppressive myeloid cells

Зміст

Статті в журналах
Дисертації
Частини книг
Тези доповідей конференцій

Добірка наукової літератури з теми "Suppressive myeloid cells"

Автор: Grafiati

Опубліковано: 30 листопада 2024

Оновлено: 31 липня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Suppressive myeloid cells".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Suppressive myeloid cells"

1

Van Valckenborgh, Els, Jo Van Ginderachter, Kiavash Movahedi, Eline Menu, and Karin Vanderkerken. "Myeloid-Derived Suppressor Cells in Multiple Myeloma." Blood 114, no. 22 (2009): 2794. http://dx.doi.org/10.1182/blood.v114.22.2794.2794.

Повний текст джерела

Анотація:

Abstract Abstract 2794 Poster Board II-770 Myeloid-derived suppressor cells (MDSCs) are a heterogeneous mix of myeloid cells in different maturation stages generated in the bone marrow. The role of MDSCs in cancer is to suppress T-cell responses, thereby likely regulating tumor progression. In mice, MDSCs are identified by the expression of the surface markers CD11b and Gr-1. Recently, Ly6G+ granulocytic (PMN-MDSC) and Ly6G− monocytic (MO-MDSC) subsets could be distinguished (Movahedi et al. Blood 2008, 111:4233-44). In multiple myeloma patients, the immune function is impaired and this is cau

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Joseph, Ann Mary, Dominique Parker, Tarik Hawkins, Nicholas Ciavattone, and Eduardo Davila. "TLR-stimulated T cells acquire resistance to MDSC mediated suppression." Journal of Immunology 198, no. 1_Supplement (2017): 205.15. http://dx.doi.org/10.4049/jimmunol.198.supp.205.15.

Повний текст джерела

Анотація:

Abstract The immunosuppressive tumor microenvironment presents a significant challenge to developing effective T cell-based cancer immunotherapies. Myeloid-derived suppressor cells (MDSCs), a heterogeneous group of cells, are a major contributor to the suppressive tumor microenvironment. MDSCs are immature myeloid cells that develop in response to chronic inflammation generated by an infection or a tumor. Currently, strategies to block MDSC-mediated suppression generate modest anti-tumor responses. This is in part due to lack of specific markers to target MDSCs and inability to simultaneously

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Parker, Katherine, and Suzanne Ostrand-Rosenberg. "HMGB1: a regulator of myeloid-derived suppressor cell potency? (66.37)." Journal of Immunology 186, no. 1_Supplement (2011): 66.37. http://dx.doi.org/10.4049/jimmunol.186.supp.66.37.

Повний текст джерела

Анотація:

Abstract Myeloid-derived suppressor cells (MDSC) are a heterogeneous population of cells that accumulate in individuals with cancer and inflammation and play a pivotal role in tumor immunity by suppressing T-cell activation and secreting proinflammatory molecules. The suppressive capacity of MDSC is mediated by immune suppressive factors such as arginase and reactive oxygen species (ROS). Nuclear protein, High Mobility Group Box1 (HMGB1), is present in nearly all cells and is released from myeloid cells as a danger response to sepsis, infection, or arthritis. Its release promotes inflammatory

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Oliver, Liliana, Rydell Alvarez, Raquel Diaz, et al. "Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator." Journal for ImmunoTherapy of Cancer 10, no. 9 (2022): e004710. http://dx.doi.org/10.1136/jitc-2022-004710.

Повний текст джерела

Анотація:

BackgroundImmune suppression is common in neoplasia and a major driver is tumor-induced myeloid dysfunction. Yet, overcoming such myeloid cell defects remains an untapped strategy to reverse suppression and improve host defense. Exposure of bone marrow progenitors to heightened levels of myeloid growth factors in cancer or following certain systemic treatments promote abnormal myelopoiesis characterized by the production of myeloid-derived suppressor cells (MDSCs) and a deficiency in antigen-presenting cell function. We previously showed that a novel immune modulator, termed ‘very small size p

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Takacs, Gregory, Christian Kreiger, Defang Luo, Guimei Tian, Loic Deleyrolle, and Jeffrey Harrison. "IMMU-21. GLIOMA-DERIVED FACTORS RECRUIT AND INDUCE AN IMMUNE SUPPRESSIVE PHENOTYPE IN BONE MARROW-DERIVED CCR2+ MYELOID CELLS." Neuro-Oncology 24, Supplement_7 (2022): vii135—vii136. http://dx.doi.org/10.1093/neuonc/noac209.519.

Повний текст джерела

Анотація:

Abstract INTRODUCTION Infiltrating immune-suppressive myeloid cells represent a tumor supportive population that contributes to immune checkpoint inhibitor resistance and poor survival in Glioblastoma (GBM) patients. We have previously characterized monocytic-myeloid derived suppressor cells (M-MDSCs) based on their dual expression of chemokine receptors CCR2 and CX3CR1(CCR2+/CX3CR1+). Genetic and pharmacologic targeting of CCR2, in combination with PD-1 blockade, reduced the percentage of M-MDSCs in the glioma-microenvironment and slowed the progression of KR158 and 005GSC murine gliomas. Add

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Frosch, Jennifer, Ilia Leontari, and John Anderson. "Combined Effects of Myeloid Cells in the Neuroblastoma Tumor Microenvironment." Cancers 13, no. 7 (2021): 1743. http://dx.doi.org/10.3390/cancers13071743.

Повний текст джерела

Анотація:

Despite multimodal treatment, survival chances for high-risk neuroblastoma patients remain poor. Immunotherapeutic approaches focusing on the activation and/or modification of host immunity for eliminating tumor cells, such as chimeric antigen receptor (CAR) T cells, are currently in development, however clinical trials have failed to reproduce the preclinical results. The tumor microenvironment is emerging as a major contributor to immune suppression and tumor evasion in solid cancers and thus has to be overcome for therapies relying on a functional immune response. Among the cellular compone

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Du, Hong, Xinchun Ding, and Cong Yan. "Metabolic reprogramming of myeloid-derived suppressive cells." Oncoscience 4, no. 3-4 (2017): 29–30. http://dx.doi.org/10.18632/oncoscience.349.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Topal Gorgun, Gullu, Hiroto Ohguchi, Teru Hideshima, et al. "Inhibition Of Myeloid Derived Suppressor Cells (MDSC) In The Multiple Myeloma Bone Marrow Microenvironment." Blood 122, no. 21 (2013): 3089. http://dx.doi.org/10.1182/blood.v122.21.3089.3089.

Повний текст джерела

Анотація:

Abstract The interaction of myeloma (MM) cells with bone marrow accessory cells induces genomic, epigenomic and functional changes which promote tumor development, progression, cell adhesion mediated-drug resistance (CAM-DR), and immune suppression. As in other cancers, bidirectional interaction between MM cells and surrounding cells regulates tumor development on the one hand, while transforming the BM microenvironment into a tumor promoting and immune suppressive milieu on the other. Recent developments in targeted therapies have indicated that generation of the most effective therapeutic st

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Petersson, Julia, Sandra Askman, Åsa Pettersson, et al. "Bone Marrow Neutrophils of Multiple Myeloma Patients Exhibit Myeloid-Derived Suppressor Cell Activity." Journal of Immunology Research 2021 (August 6, 2021): 1–10. http://dx.doi.org/10.1155/2021/6344344.

Повний текст джерела

Анотація:

Activated normal density granulocytes (NDGs) can suppress T-cell responses in a similar way as myeloid-derived suppressor cells (MDSCs). In this study, we tested the hypothesis that NDGs from blood and bone marrow of multiple myeloma (MM) patients have the ability to suppress T-cells, as MDSC. MM is an incurable plasma cell malignancy of the bone marrow. Like most malignancies, myeloma cells alter its microenvironment to promote tumor growth, including inhibition of the immune system. We found that MM NDG from the bone marrow suppressed proliferation of T-cells, in contrast to healthy donors.

Стилі APA, Harvard, Vancouver, ISO та ін.

10

D’Amico, Lucia, Sahil Mahajan, Aude-Hélène Capietto, et al. "Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer." Journal of Experimental Medicine 213, no. 5 (2016): 827–40. http://dx.doi.org/10.1084/jem.20150950.

Повний текст джерела

Анотація:

Tumor–stroma interactions contribute to tumorigenesis. Tumor cells can educate the stroma at primary and distant sites to facilitate the recruitment of heterogeneous populations of immature myeloid cells, known as myeloid-derived suppressor cells (MDSCs). MDSCs suppress T cell responses and promote tumor proliferation. One outstanding question is how the local and distant stroma modulate MDSCs during tumor progression. Down-regulation of β-catenin is critical for MDSC accumulation and immune suppressive functions in mice and humans. Here, we demonstrate that stroma-derived Dickkopf-1 (Dkk1) ta

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Дисертації з теми "Suppressive myeloid cells"

1

Benner, Brooke Nicole. "Enhancing Immunotherapy for Cancer by Targeting Suppressive Myeloid cells." The Ohio State University, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=osu1583766367545941.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Ortiz, Myrna Lillian. "Immature Myeloid Cells Promote Tumor Formation Via Non-Suppressive Mechanism." Scholar Commons, 2014. https://scholarcommons.usf.edu/etd/5089.

Повний текст джерела

Анотація:

ABSTRACT Although there is ample evidence linking chronic inflammation with cancer, the cellular mechanisms involved in early events leading to tumor development remain unclear. Myeloid cells are an intricate part of inflammation. They consist of mature cells represented by macrophages, dendritic cells and granulocytes and a population of Immature Myeloid Cells (IMC), which in healthy individuals are cells in transition to mature cells. There is a substantial expansion of IMC in cancer and many other pathological conditions which is associated with pathologic activation of these cells. As a re

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Collazo, Ruiz Michelle Marie. "The Role of Tumor Suppressors, SHIP and Rb, in Immune Suppressive Cells." Scholar Commons, 2012. http://scholarcommons.usf.edu/etd/4016.

Повний текст джерела

Анотація:

Regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSC) have been extensively studied in the past 30-40 years. Their potent suppressive capacity shown in several pathological and clinical settings, such as cancer and transplantation, has made it evident that better understanding their development and function is critical. Specifically, Tregs play a pivotal role in preventing autoimmunity, graft-versus-host disease (GvHD), and organ graft rejection. We previously demonstrated that germline or induced SH2 domain-containing inositol 5-phosphatase (SHIP) deficiency in the host abr

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Zwing, Natalie [Verfasser], Falk [Akademischer Betreuer] Nimmerjahn, Falk [Gutachter] Nimmerjahn, and Gerhard [Gutachter] Krönke. "Spatial Distribution of Suppressive Myeloid Cells and Cytotoxic T Cells in Colorectal Cancer / Natalie Zwing ; Gutachter: Falk Nimmerjahn, Gerhard Krönke ; Betreuer: Falk Nimmerjahn." Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2020. http://d-nb.info/123423856X/34.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Boyer, Thomas. "Impact des cellules myéloïdes immunosuppressives dans l’induction de cellules souches cancéreuses." Electronic Thesis or Diss., Bordeaux, 2024. http://www.theses.fr/2024BORD0221.

Повний текст джерела

Анотація:

Le micro-environnement tumoral est fortement influencé par les cellules myéloïdes, dont les macrophages, les neutrophiles et les monocytes sont des représentants majeurs. Les recherches des dernières décennies ont montré que presque toutes les tumeurs sont infiltrées par des cellules myéloïdes, rendant impossible l'existence de tumeurs "froides" en ce qui concerne ces cellules. De plus, les résultats de nombreuses études cliniques se focalisant sur le compartiment immunitaire myéloïde montrent clairement que ces cellules sont presque universellement associées avec un pronostique clinique négat

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Ricchetti, Giuseppe Antonio. "An examination of the suppression of IL-10 suppression of TNF in myeloid cells." Thesis, Imperial College London, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.427864.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Ko, Jennifer S. "Mechanism of Myeloid-Derived Suppressor Cell Accumulation in Cancer and Susceptibility to Reversal by Sunitinib." Case Western Reserve University School of Graduate Studies / OhioLINK, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=case1259869673.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Cabbage, Sarah E. "Reversible regulatory T cell-mediated suppression of myelin basic protein-specific T cells /." Thesis, Connect to this title online; UW restricted, 2006. http://hdl.handle.net/1773/5034.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Corzo, Cesar Alexander. "Regulatory Mechanism of Myeloid Derived Suppressor Cell Activity." Scholar Commons, 2010. http://scholarcommons.usf.edu/etd/3561.

Повний текст джерела

Анотація:

Myeloid-derived suppressor cells (MDSC) are a major component of the immune suppressive network that develops during cancer. MDSC down-regulate immune surveillance and antitumor immunity and facilitate tumor growth. The ability of MDSC to suppress T cell responses has been documented; however the mechanisms regulating this suppression remain to be understood. This work proposes a biological dichotomy of MDSC regulated by the tumor microenvironment. In peripheral lymphoid organs MDSC cause T-cell non-responsiveness that is antigen-specific. These MDSC have increased expression of NOX2, enabling

Стилі APA, Harvard, Vancouver, ISO та ін.

10

TUMINO, NICOLA. "In HIV+ patients, Myeloid Derived Suppressor Cells induce T cell anergy by suppressing CD3ζ expression through ELF-1 inhibition". Doctoral thesis, Università degli Studi di Roma "Tor Vergata", 2013. http://hdl.handle.net/2108/211078.

Повний текст джерела

Анотація:

The CD3ζ chain is indispensable for coupling antigen recognition to T cell response. During HIV infection, a down-modulation of CD3ζ was found on T cells, contributing to T cell anergy. It has been shown that circulating myeloid derived suppressor cells (MDSC) are elevated in HIV+ patients, and correlate with disease progression. In this work, we studied the correlation between MDSC frequency and T cell CD3ζ expression. Moreover, we investigated the mechanisms of CD3ζ decrease exploited by MDSC. CD3ζ expression and MDSC frequency were evaluated by flow cytometry on PBMC from 105 HIV+

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Частини книг з теми "Suppressive myeloid cells"

1

Derré, Laurent. "Myeloid-Derived Suppressive Cells in the Tumor Contexture." In Handbook of Cancer and Immunology. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-030-80962-1_381-1.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Papaioannou, Antonis Stylianos, Athina Boumpas, Miranta Papadopoulou, Aikaterini Hatzioannou, Themis Alissafi, and Panayotis Verginis. "Measuring Suppressive Activity and Autophagy in Myeloid-Derived Suppressor Cells." In Methods in Molecular Biology. Springer US, 2020. http://dx.doi.org/10.1007/978-1-0716-1060-2_9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Ma, Ge, Ping-Ying Pan, and Shu-Hsia Chen. "Myeloid-Derived Suppressive Cells and Their Regulatory Mechanisms in Cancer." In Innate Immune Regulation and Cancer Immunotherapy. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-9914-6_13.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Bueno, Valquiria, and Graham Pawelec. "Myeloid-Derived Suppressive Cells in Ageing and Age-Related Diseases." In Healthy Ageing and Longevity. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-87532-9_4.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Rodríguez, Paulo C., and Augusto C. Ochoa. "Arginine Metabolism, a Major Pathway for the Suppressive Function of Myeloid-Derived Suppressor Cells." In Tumor-Induced Immune Suppression. Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4899-8056-4_13.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Serafini, Paolo, and Vincenzo Bronte. "Myeloid-Derived Suppressor Cells in Tumor-Induced T Cell Suppression and Tolerance." In Tumor-Induced Immune Suppression. Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4899-8056-4_4.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Zilio, Serena, Giacomo Desantis, Mariacristina Chioda, and Vincenzo Bronte. "Tumour-Induced Immune Suppression by Myeloid Cells." In Tumour-Associated Macrophages. Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4614-0662-4_4.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Vlachou, Katerina, and Panayotis Verginis. "In Vitro Suppression of CD4+ T-Cell Responses by Murine and Human Myeloid-Derived Suppressor Cells." In Methods in Molecular Biology. Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-8938-6_9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Maltsev, Dmytro. "Efficacy of rituximab in autism spectrum disorders associated with genetic deficiency of the folate cycle with signs of antineuronal autoimmunity." In IMMUNODIAGNOSTICS AND IMMUNOTHERAPY OF NEUROPSYCHIATRIC DISORDERS IN CHILDREN. TECHNOLOGY CENTER PC, 2025. https://doi.org/10.15587/978-617-8360-21-4.ch12.

Повний текст джерела

Анотація:

Advances in genetics, molecular biology, and immunology over the past decades have significantly changed our understanding of the etiology and pathogenesis of autism spectrum disorders (ASD) in children. One of the key advances in this direction is the elucidation of the association of genetic deficiency of the folate cycle (GDFC) with ASD, evidence for which is based on the results of at least 5 meta-analyses of randomized controlled clinical trials and a number of additional controlled trials, the data of which have not yet been properly summarized. It has been established that GDFC leads to

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Micouin, Anne, and Brigitte Bauvois. "Expression of Dipeptidylpeptidase IV (DPP IV/CD26) Activity on Human Myeloid and B Lineage Cells, and Cell Growth Suppression by the Inhibition of DPP IV Activity." In Advances in Experimental Medicine and Biology. Springer US, 1997. http://dx.doi.org/10.1007/978-1-4757-9613-1_26.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Suppressive myeloid cells"

1

Yan, Cong, Xinchun Ding, Lingyan Wu, and Hong Du. "Abstract A12: Establishment of myeloid lineage cell line that resembles myeloid-derived suppressive cells." In Abstracts: AACR Special Conference: Metabolism and Cancer; June 7-10, 2015; Bellevue, WA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1557-3125.metca15-a12.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Marx, M., S. Troschke-Meurer, M. Zumpe, H. Lode, and N. Siebert. "Blockade of suppressive myeloid cells is effective against neuroblastoma." In 32. Jahrestagung der Kind-Philipp-Stiftung für pädiatrisch onkologische Forschung. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1687139.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Bouchkouj, Najat, Haiying Qin, Susana Galli, et al. "Abstract 1332: Pediatric sarcomas are infiltrated with myeloid derived suppressive cells." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-1332.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Condamine, Thomas C., Vinit Kumar, and Dmitry I. Gabrilovich. "Abstract 3176: Linking suppressive activity and ER-Stress in Myeloid Derived Suppressor Cells." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-3176.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Markowitz, Joseph, Taylor R. Brooks, and William E. Carson. "Abstract 3663: Immune suppressive myeloid cells expansion in vitro requires a simulated tumor microenvironment." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-3663.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Bodogai, Monica, Catalina Lee Chang, and Arya Biragyn. "Abstract 3671: Myeloid-derived suppressive cells require education from tumor-evoked Bregs to mediate metastasis." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-3671.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Baugh, Aaron G., Edgar Gonzalez, Sabrina K. Zhong, et al. "874 Epigenetic modulation of myeloid derived suppressor cells decreases suppressive signaling through the STAT3 pathway." In SITC 39th Annual Meeting (SITC 2024) Abstracts. BMJ Publishing Group Ltd, 2024. http://dx.doi.org/10.1136/jitc-2024-sitc2024.0874.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Takacs, Gregory, Julia Garcia, Alexandra Sherman, Christian Kreiger, Defang Luo, and Jeffrey Harrison. "987 Glioma-derived factors induce an immune suppressive phenotype in bone marrow-derived CCR2+ myeloid cells." In SITC 38th Annual Meeting (SITC 2023) Abstracts. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/jitc-2023-sitc2023.0987.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Markowitz, Joseph, Bonnie K. Paul, Taylor R. Brooks, et al. "Abstract 456: Immune-suppressive myeloid cells are induced during disease progression in patients with advanced pancreatic adenocarcinoma." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-456.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Hamilton, Melisa J., Momir Bosiljcic, Bryant T. Harbourne, et al. "Abstract A9: Immune suppressive myeloid cells induced by hypoxic mammary tumor cells persist after primary tumor resection and promote metastatic growth." In Abstracts: AACR Special Conference on Tumor Invasion and Metastasis - January 20-23, 2013; San Diego, CA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.tim2013-a9.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!